OTTAWA (Reuters) – A Canadian decision on whether to approve Pfizer Inc’s COVID-19 vaccine for those aged 5 to 11 will not come before mid- to end-November, a senior official said on Friday.
“I think we’re still at least a few weeks away from a final decision … we’ve received some additional information just this past week that we’rem looking through,” Supriya Sharma, the federal health ministry’s chief medical adviser, told a briefing.
(Reporting by David Ljunggren)
